| 注册
首页|期刊导航|中国当代医药|抗病毒治疗对慢性乙型肝炎患者调节性T细胞影响的研究进展

抗病毒治疗对慢性乙型肝炎患者调节性T细胞影响的研究进展

牟花妮 蒋玉凤

中国当代医药Issue(23):15-18,4.
中国当代医药Issue(23):15-18,4.

抗病毒治疗对慢性乙型肝炎患者调节性T细胞影响的研究进展

Research progress of antiviral therapy influencing on regulatory T cell in patients with chronic hepatitis B

牟花妮 1蒋玉凤1

作者信息

  • 1. 泸州医学院附属医院感染消化科,四川泸州 646000
  • 折叠

摘要

Abstract

Antiviral therapy inhibits viral replication and also has some influence on body’s immunity in patients with chronic hepatitis B.Regulatory T cell,a subset of T cells,has an immunomodulatory function in v iv o and can inhibit spe-cific T cell response in HBV infection patients.Study of antiviral therapy influencing on amount of regulatory T cell and its function in patients with chronic hepatitis B can lay foundations for probing into more ideal immunological indica-tors to assess the anti-viral responses,therapeutic efficacy,predict the termination of treatment and recurrence after ceasing medication,disease prognosis,and may also point out the direction for developing more optimal strategies of an-tiviral treatment in patients with chronic hepatitis B.

关键词

慢性乙型肝炎/抗病毒治疗/调节性T细胞

Key words

Chronic hepatitis B/Antiviral therapy/Regulatory T cell

分类

医药卫生

引用本文复制引用

牟花妮,蒋玉凤..抗病毒治疗对慢性乙型肝炎患者调节性T细胞影响的研究进展[J].中国当代医药,2015,(23):15-18,4.

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文